Science 37 Holdings Top Management
Science 37 employs about 460 people. The company is managed by 14 executives with a total tenure of roughly 1074 years, averaging almost 76.0 years of service per executive, having 32.86 employees per reported executive. Evaluation of Science 37's management performance can provide insight into the firm performance.
Science |
Science 37 Management Team Effectiveness
The company has return on total asset (ROA) of (0.2831) % which means that it has lost $0.2831 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1852) %, meaning that it created substantial loss on money invested by shareholders. Science 37's management efficiency ratios could be used to measure how well Science 37 manages its routine affairs as well as how well it operates its assets and liabilities.Science 37 Workforce Comparison
Science 37 Holdings is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 8,174. Science 37 holds roughly 460 in number of employees claiming about 6% of equities under Health Care industry.
The company has Profit Margin (PM) of (2.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.6) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.6. Science 37 Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Science 37 insiders, such as employees or executives, is commonly permitted as long as it does not rely on Science 37's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Science 37 insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Michael Shipton over a year ago Disposition of 3006 shares by Michael Shipton of Science 37 at 5.73 subject to Rule 16b-3 | ||
Michael Shipton over a year ago Exercise or conversion by Michael Shipton of 100000 shares of Science 37 subject to Rule 16b-3 | ||
Rollins Emily over a year ago Acquisition by Rollins Emily of 27575 shares of Science 37 subject to Rule 16b-3 | ||
Darcy Forman over a year ago Exercise or conversion by Darcy Forman of 288972 shares of Science 37 subject to Rule 16b-3 | ||
Darcy Forman over a year ago Disposition of 211538 shares by Darcy Forman of Science 37 subject to Rule 16b-3 | ||
Pellizzari Christine A over a year ago Exercise or conversion by Pellizzari Christine A of 16667 shares of Science 37 subject to Rule 16b-3 | ||
Hubbard John W over a year ago Exercise or conversion by Hubbard John W of 40983 shares of Science 37 subject to Rule 16b-3 | ||
Darcy Forman over a year ago Acquisition by Darcy Forman of 492916 shares of Science 37 subject to Rule 16b-3 |
Science 37 Notable Stakeholders
A Science 37 stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Science 37 often face trade-offs trying to please all of them. Science 37's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Science 37's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Irena Lambridis | VP Compliance | Profile | |
| Tyler Horn | VP Staff | Profile | |
| Troy Bryenton | Chief Officer | Profile | |
| Christine JD | Chief Secretary | Profile | |
| David Coman | CEO Director | Profile | |
| Mike Zaranek | Chief Officer | Profile | |
| Elisa Cascade | Chief Officer | Profile | |
| Christopher Ceppi | Chief Officer | Profile | |
| Margie Kooman | Vice Communications | Profile | |
| Michael Shipton | Chief Officer | Profile | |
| Drew Bustos | Chief Officer | Profile | |
| James Young | Chief Officer | Profile | |
| Darcy Forman | Chief Officer | Profile | |
| Jonathan MD | Chief Officer | Profile |
Science 37 Workforce Analysis
Traditionally, organizations such as Science 37 use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Science 37 within its industry.Science 37 Manpower Efficiency
Return on Science 37 Manpower
| Revenue Per Employee | 131K | |
| Revenue Per Executive | 4.3M | |
| Net Loss Per Employee | 271K | |
| Net Loss Per Executive | 8.9M | |
| Working Capital Per Employee | 224K | |
| Working Capital Per Executive | 7.4M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Science Stock
If you are still planning to invest in Science 37 Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science 37's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |